BioNTech SE Stock Forecast

Stock Price Forecast

According to 20 analysts polled by S&P Global, BioNTech SE stock has a consensus rating of "Buy" and an average price target of $120.14. The average 1-year stock price forecast is 18.24% higher than the current stock price, while the lowest is $75.6 (-25.60%) and the highest is $144.23 (+41.94%).

Price Target: $120.14 (+18.24%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$75.6	$120.14	$128.34	$144.23
Change	-25.60%	+18.24%	+26.31%	+41.94%

Analyst Ratings

The average analyst rating for BioNTech SE stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	13	13	13	14	14	14
Buy	1	1	1	1	1	1
Hold	5	3	5	5	5	4
Sell	0	1	0	0	0	1
Strong Sell	0	0	0	0	0	0
Total	19	18	19	20	20	20

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Terence Flynn Morgan Stanley	Morgan Stanley	Buy Reiterates $115	Buy	Reiterates	$115	+13.18%	Aug 31, 2026
Geoff Meacham Citi	Citi	Buy Reiterates $125	Buy	Reiterates	$125	+23.02%	Aug 31, 2026
John Newman Canaccord Genuity	Canaccord Genuity	Buy Maintains $142 → $136	Buy	Maintains	$142 → $136	+33.85%	Aug 31, 2026
Evan Seigerman BMO Capital	BMO Capital	Buy Maintains $128	Buy	Maintains	$128	+25.97%	Aug 28, 2026
Emmanuel Papadakis Deutsche Bank	Deutsche Bank	Buy Maintains $140	Buy	Maintains	$140	+37.78%	Aug 26, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.81B

from 2.87B

-37.05%

from 2.87B

Revenue Next Year

1.81B

from 1.81B

0.35%

from 1.81B

EPS This Year

-4.97

from -0.48

EPS Next Year

-4.86

from -4.97

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	18.98B	17.31B	3.82B	2.75B	2.87B	1.81B
Revenue Growth	3,834.63%	-8.78%	-77.94%	-27.96%	4.32%	-37.05%
Gross Profit	16.07B	14.32B	3.22B	2.21B	2.26B	1.48B
Gross Margin	84.66%	82.70%	84.29%	80.32%	78.70%	81.91%
Operating Income	14.85B	11.92B	971.80M	-1.29B	-1.27B	-1.82B
Net Income	10.29B	9.43B	930.30M	-665.30M	-1.14B	-1.38B
EPS	-	-	-	-	-0.48	-4.97
Free Cash Flow	-646.60M	12.01B	4.14B	-548.20M	-1.10B	-1.75B
No. Analysts	-	-	-	-	-	18

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	2.2B
Avg	1.8B
Low	1.7B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-24.8%
Avg	-37.0%
Low	-42.4%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-3.30
Avg	-4.97
Low	-7.36

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-